Literature DB >> 14561199

Toll-like receptors and inflammation in the CNS.

Sung Joong Lee1, Soojin Lee.   

Abstract

The innate immune system recognizes "non-self" by employing a set of germline-encoded receptors called Toll-like receptors (TLRs), originally characterized in Drosophila. TLRs are involved in the recognition of various microbial-derived molecules, including lipopolysaccharide (LPS), lipoteichoic acid (LTA), and peptidoglycan (PGN), as well as unmethylated bacterial DNA. The TLR-mediated intracellular signaling pathways converge to activate nuclear factor-kappa B (NF-kappaB) and c-Jun N-terminal kinases (JNKs), which induce the transcription of a series of cytokine/chemokine genes that are involved in the initiation or regulation of the inflammatory response. It is now known that, like other peripheral organs, the central nervous system (CNS) is also under constitutive immune surveillance by CNS-resident glial cells (microglia and astrocytes) and CNS-infiltrating immune cells. The recent progress in our understanding of TLR functions in the innate immune response sheds new light on how inflammatory immune responses are initiated within the CNS. In this review, we discuss recent studies on TLRs and their ligands, signal transduction pathways activated by TLRs, and the mechanisms through which these various activation events occur. Finally, we discuss how TLRs might play similar important roles in CNS inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14561199     DOI: 10.2174/1568010023344698

Source DB:  PubMed          Journal:  Curr Drug Targets Inflamm Allergy        ISSN: 1568-010X


  48 in total

Review 1.  Toll-like receptors in defense and damage of the central nervous system.

Authors:  Rajagopal N Aravalli; Phillip K Peterson; James R Lokensgard
Journal:  J Neuroimmune Pharmacol       Date:  2007-04-03       Impact factor: 4.147

2.  Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors.

Authors:  Jonathan R Weinstein; Sarah Swarts; Caroline Bishop; Uwe-Karsten Hanisch; Thomas Möller
Journal:  Glia       Date:  2008-01-01       Impact factor: 7.452

Review 3.  Neurobiology of injury to the developing brain.

Authors:  Wenbin Deng
Journal:  Nat Rev Neurol       Date:  2010-05-18       Impact factor: 42.937

Review 4.  Role of the innate immune system in the pathogenesis of multiple sclerosis.

Authors:  Roopali Gandhi; Alice Laroni; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2010-04-15       Impact factor: 3.478

5.  Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice.

Authors:  Fumihiro Kawakita; Masashi Fujimoto; Lei Liu; Fumi Nakano; Yoshinari Nakatsuka; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2016-10-13       Impact factor: 5.590

Review 6.  Mitochondrial oxidative stress initiates visual loss in sympathetic ophthalmia.

Authors:  Yutaka Kaneko; Narsing A Rao
Journal:  Jpn J Ophthalmol       Date:  2012-04-03       Impact factor: 2.447

Review 7.  Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles.

Authors:  Xiaoming Hu; Anthony K F Liou; Rehana K Leak; Mingyue Xu; Chengrui An; Jun Suenaga; Yejie Shi; Yanqin Gao; Ping Zheng; Jun Chen
Journal:  Prog Neurobiol       Date:  2014-06-09       Impact factor: 11.685

8.  Lipopolysaccharide-induced down-regulation of Ca2+ release-activated Ca2+ currents (I CRAC) but not Ca2+-activated TRPM4-like currents (I CAN) in cultured mouse microglial cells.

Authors:  Andreas Beck; Reinhold Penner; Andrea Fleig
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

9.  Therapeutic targeting of astrocytes after traumatic brain injury.

Authors:  Jessica Shields; Donald E Kimbler; Walid Radwan; Nathan Yanasak; Sangeetha Sukumari-Ramesh; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2011-11-09       Impact factor: 6.829

10.  The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.

Authors:  Beichu Guo; Elmer Y Chang; Genhong Cheng
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.